MicroPort NeuroScientific Salute del bilancio

Salute finanziaria criteri di controllo 6/6

MicroPort NeuroScientific ha un patrimonio netto totale di CN¥1.7B e un debito totale di CN¥0.0, che porta il suo rapporto debito/patrimonio netto a 0%. Le sue attività totali e le sue passività totali sono rispettivamente CN¥2.1B e CN¥373.2M. L'EBIT di MicroPort NeuroScientific è CN¥294.8M rendendo il suo rapporto di copertura degli interessi -22.6. Ha liquidità e investimenti a breve termine pari a CN¥1.1B.

Informazioni chiave

Rapporto debito/patrimonio netto

CN¥0

Debito

Indice di copertura degli interessi	-22.6x
Contanti	CN¥1.13b
Patrimonio netto	CN¥1.71b
Totale passività	CN¥373.18m
Totale attività	CN¥2.08b

Aggiornamenti recenti sulla salute finanziaria

Nessun aggiornamento

Recent updates

Some MicroPort NeuroTech Limited (HKG:2172) Shareholders Look For Exit As Shares Take 28% Pounding

Jun 29

Shareholders Will Be Pleased With The Quality of MicroPort NeuroTech's (HKG:2172) Earnings

Sep 29

Investors Could Be Concerned With MicroPort NeuroTech's (HKG:2172) Returns On Capital

Aug 04

Analisi della posizione finanziaria

Passività a breve termine: Le attività a breve termine ( CN¥1.5B ) di 2172 superano le sue passività a breve termine ( CN¥286.9M ).

Passività a lungo termine: Le attività a breve termine di 2172 ( CN¥1.5B ) superano le sue passività a lungo termine ( CN¥86.2M ).

Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: 2172 è esente da debiti.

Riduzione del debito: 2172 non aveva debiti 5 anni fa.

Copertura del debito: 2172 non ha debiti, pertanto non deve essere coperto dal flusso di cassa operativo.

Copertura degli interessi: 2172 non ha debiti, pertanto la copertura dei pagamenti degli interessi non è un problema.

MicroPort NeuroScientific Salute del bilancio

Salute finanziaria criteri di controllo 6/6

Informazioni chiave

Aggiornamenti recenti sulla salute finanziaria

Recent updates

Investor sentiment improves as stock rises 16%

MicroPort NeuroScientific Corporation (SEHK:2172) commences an Equity Buyback Plan for 58,265,810 shares, representing 10% of its issued share capital, under the authorization approved on June 26, 2024.

Upcoming dividend of HK$0.08 per share

First half 2024 earnings released: EPS: CN¥0.25 (vs CN¥0.11 in 1H 2023)

MicroPort NeuroTech Limited to Report First Half, 2024 Results on Aug 28, 2024

Microport Neurotech Limited Announces Change of Company Secretary

Some MicroPort NeuroTech Limited (HKG:2172) Shareholders Look For Exit As Shares Take 28% Pounding

MicroPort NeuroTech Limited Approves Final Dividend for the Year Ended 31 December 2023

MicroPort NeuroTech (HKG:2172) Will Want To Turn Around Its Return Trends

Consensus revenue estimates decrease by 13%, EPS upgraded

MicroPort NeuroTech Limited, Annual General Meeting, Jun 26, 2024

MicroPort NeuroTech Limited Proposes Final Ordinary Dividend for the Year Ended 31 December 2023, Payable on 22 August 2024

MicroPort NeuroTech Limited to Report Fiscal Year 2023 Final Results on Mar 27, 2024

Is MicroPort NeuroTech Limited (HKG:2172) Trading At A 36% Discount?

Returns On Capital At MicroPort NeuroTech (HKG:2172) Have Hit The Brakes

Investor sentiment deteriorates as stock falls 22%

Investor sentiment deteriorates as stock falls 16%

MicroPort NeuroTech Limited Announces Executive Changes

Calculating The Fair Value Of MicroPort NeuroTech Limited (HKG:2172)

Shareholders Will Be Pleased With The Quality of MicroPort NeuroTech's (HKG:2172) Earnings

First half 2023 earnings released: EPS: CN¥0.11 (vs CN¥0.20 loss in 1H 2022)

MicroPort NeuroTech Limited to Report First Half, 2023 Results on Aug 30, 2023

Investors Could Be Concerned With MicroPort NeuroTech's (HKG:2172) Returns On Capital

MicroPort NeuroTech Limited Provides Earnings Guidance for the Six Months Ended 30 June 2023

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Less than half of directors are independent

First half 2022 earnings released

Microport Neurotech Limited Announces Approval of Numen Coil Embolization System by the Japanese Ministry of Health, Labour and Welfare for Final Marketing Authorisation

MicroPort NeuroTech Limited to Report Q2, 2022 Results on Aug 26, 2022

MicroPort NeuroTech Limited has completed an IPO in the amount of HKD 337.568 million.

Less than half of directors are independent

Analisi della posizione finanziaria

Storia e analisi del rapporto debito/patrimonio netto

Bilancio

Scoprire le aziende sane